计算机断层扫描中静脉注射造影剂的肾脏相关不良反应
Renal-related adverse effects of intravenous contrast media in computed tomography.
作者信息
Leow Kheng Song, Wu Yi Wei, Tan Cher Heng
机构信息
Department of Diagnostic Radiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433.
出版信息
Singapore Med J. 2015 Apr;56(4):186-93. doi: 10.11622/smedj.2015057.
Abstract
Renal-related adverse effects of intravascular contrast media (CM) include contrast-induced nephropathy in computed tomography and angiography. While large retrospective studies have been published, the exact pathogenesis of this condition is still unknown. We review the main international guidelines, including the American College of Radiology white paper and the guidelines of European Society of Urogenital Radiology, Royal College of Radiologists and Canadian Association of Radiologists, as well as their references, regarding this subject. We present a simplified, concise approach to renal-related adverse effects of CM, taking into consideration the basis for each recommendation in these published guidelines. This will allow the reader to better understand the rationale behind appropriate patient preparation for cross-sectional imaging.
摘要
血管内造影剂（CM）的肾脏相关不良反应包括计算机断层扫描和血管造影中对比剂诱发的肾病。虽然已经发表了大量回顾性研究，但这种情况的确切发病机制仍然未知。我们回顾了主要的国际指南，包括美国放射学会白皮书以及欧洲泌尿生殖放射学会、皇家放射科医师学院和加拿大放射科医师协会的指南及其参考文献，涉及这一主题。我们提出了一种针对CM肾脏相关不良反应的简化、简明方法，同时考虑了这些已发表指南中每项建议的依据。这将使读者能够更好地理解为横断面成像进行适当患者准备背后的基本原理。
相似文献
1
Renal-related adverse effects of intravenous contrast media in computed tomography.计算机断层扫描中静脉注射造影剂的肾脏相关不良反应
Singapore Med J. 2015 Apr;56(4):186-93. doi: 10.11622/smedj.2015057.
2
What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.与当前证据支持的措施相比，放射科医生在预防对比剂肾病（CIN）方面做了些什么？一项针对欧洲放射科医生关于计算机断层扫描相关CIN的调查。
Acta Radiol. 2008 Apr;49(3):310-20. doi: 10.1080/02841850701858257.
3
European Society of Urogenital Radiology guidelines on administering contrast media.欧洲泌尿生殖放射学会关于使用造影剂的指南。
Abdom Imaging. 2003 Mar-Apr;28(2):187-90. doi: 10.1007/s00261-001-0186-5.
4
Acute nephropathy after contrast agent administration for computed tomography perfusion and computed tomography angiography in patients with acute ischemic stroke.急性缺血性卒中患者在进行计算机断层扫描灌注成像和计算机断层血管造影时使用造影剂后发生的急性肾病。
Int J Stroke. 2015 Jun;10(4):E35-6. doi: 10.1111/ijs.12448.
5
How to avoid CIN: guidelines from the European Society of Urogenital Radiology.如何避免对比剂肾病：欧洲泌尿生殖放射学会指南
Nephrol Dial Transplant. 2005 Feb;20 Suppl 1:i18-22. doi: 10.1093/ndt/gfh1070.
6
Maximum Arterial Contrast Concentrations With Computed Tomography and Left Ventriculography: Implications for Contrast Nephrotoxicity Risk.计算机断层扫描和左心室造影的最大动脉对比剂浓度：对对比剂肾病风险的影响。
J Comput Assist Tomogr. 2017 Nov/Dec;41(6):976-982. doi: 10.1097/RCT.0000000000000624.
7
Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China.非离子型碘对比剂所致药物不良反应的临床观察：来自中国重庆109255例接受CT增强检查患者的结果
Br J Radiol. 2015 Mar;88(1047):20140491. doi: 10.1259/bjr.20140491. Epub 2015 Jan 13.
8
Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.采取预防措施治疗的慢性肾功能不全患者在接受多排螺旋计算机断层血管造影时对比剂肾病的发生率。
Am J Cardiol. 2008 Aug 1;102(3):353-6. doi: 10.1016/j.amjcard.2008.03.067. Epub 2008 May 29.
9
[Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].[碘化造影剂与肾病。估算肌酐清除率以更好地评估肾功能和剂量]
Ugeskr Laeger. 2004 Jun 21;166(26-31):2566-72.
10
[Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].[碘化造影剂与肾病——新的建议。通过估算肌酐清除率更好地评估肾功能及确定剂量]
Lakartidningen. 2003 Mar 6;100(10):840-3, 846-8.
引用本文的文献
1
Algorithm-based approach to focal liver lesions in contrast-enhanced ultrasound.基于算法的超声造影对肝脏局灶性病变的诊断方法
Australas J Ultrasound Med. 2022 Jul 4;25(3):142-153. doi: 10.1002/ajum.12306. eCollection 2022 Aug.
2
Safety of a rapid outpatient hydration protocol for patients with renal impairment requiring intravenous iodinated contrast media for computed tomography.肾功能损害患者 CT 检查需静脉注射含碘对比剂时，快速门诊补液方案的安全性。
Singapore Med J. 2021 Nov;62(11):588-593. doi: 10.11622/smedj.2020078. Epub 2020 May 27.
3
Utility of conventional aortic root shot angiography for SAPIEN 3 prosthesis sizing in TAVI: feasibility and inter-reader variability.传统主动脉根部造影在 TAVI 中用于 SAPIEN 3 假体 sizing 的效用：可行性和读者间可变性。
Open Heart. 2019 Dec 29;6(2):e001201. doi: 10.1136/openhrt-2019-001201. eCollection 2019.
4
Effect of Repeated Injection of Iodixanol on Renal Function in Healthy Wistar Rats Using Functional MRI.使用功能磁共振成像研究重复注射碘克沙醇对健康 Wistar 大鼠肾功能的影响。
Biomed Res Int. 2018 Apr 4;2018:7272485. doi: 10.1155/2018/7272485. eCollection 2018.
5
Safety enhancement in adult body computed tomography scanning: comparison of iodixanol versus iohexol.成人身体计算机断层扫描中的安全性增强：碘克沙醇与碘海醇的比较。
Springerplus. 2016 Feb 24;5:148. doi: 10.1186/s40064-016-1754-z. eCollection 2016.
本文引用的文献
1
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.接受经皮冠状动脉介入治疗患者急性肾损伤的当代发病率、预测因素及预后：来自国家心血管数据注册库（NCDR）导管介入治疗注册研究的见解
JACC Cardiovasc Interv. 2014 Jan;7(1):1-9. doi: 10.1016/j.jcin.2013.06.016.
2
The use of nitrates in the prevention of contrast-induced nephropathy in patients hospitalized after undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗后住院患者中使用硝酸盐预防对比剂肾病。
J Cardiovasc Pharmacol Ther. 2014 May;19(3):310-4. doi: 10.1177/1074248413515077. Epub 2013 Dec 23.
3
Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.急诊经皮冠状动脉介入治疗患者尿酸与对比剂诱导肾病的关系。
Am J Emerg Med. 2014 Feb;32(2):119-23. doi: 10.1016/j.ajem.2013.10.011. Epub 2013 Oct 11.
4
Meta-analysis of the effect of automated contrast injection devices versus manual injection and contrast volume on risk of contrast-induced nephropathy.自动化对比剂注射装置与手动注射和对比剂用量对对比剂肾病风险影响的荟萃分析。
Am J Cardiol. 2014 Jan 1;113(1):49-53. doi: 10.1016/j.amjcard.2013.08.040. Epub 2013 Oct 3.
5
Hyperuricemia as a risk factor for progressive renal insufficiency after coronary intervention in patients with chronic kidney disease.高尿酸血症作为慢性肾脏病患者冠状动脉介入术后肾功能进行性减退的一个危险因素。
Cardiovasc Interv Ther. 2010 Jul;25(2):105-11. doi: 10.1007/s12928-010-0021-4. Epub 2010 May 29.
6
Contrast-induced nephropathy: pharmacology, pathophysiology and prevention.对比剂肾病：药理学、病理生理学与预防。
Insights Imaging. 2013 Dec;4(6):811-20. doi: 10.1007/s13244-013-0291-3. Epub 2013 Oct 3.
7
Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease.冠状动脉造影术后对比剂诱导的急性肾损伤：一项伴或不伴慢性肾脏病的住院患者队列研究。
Nephrol Dial Transplant. 2013 Jun;28(6):1463-71. doi: 10.1093/ndt/gft082. Epub 2013 Apr 12.
8
Measures used to treat contrast-induced nephropathy: overview of reviews.用于治疗对比剂诱导肾病的方法：系统评价概述。
Br J Radiol. 2013 Jan;86(1021):20120272. doi: 10.1259/bjr.20120272.
9
Understanding nephrogenic systemic fibrosis.了解肾源性系统性纤维化。
Int J Nephrol. 2012;2012:912189. doi: 10.1155/2012/912189. Epub 2012 Nov 4.
10
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy.欧洲肾脏最佳实践（ERBP）关于改善全球肾脏病预后组织（KDIGO）急性肾损伤临床实践指南的立场声明：第1部分：定义、保守治疗及造影剂肾病。
Nephrol Dial Transplant. 2012 Dec;27(12):4263-72. doi: 10.1093/ndt/gfs375. Epub 2012 Oct 8.
Zotero 插件